Chinese President Xi Jinping is set to chair a rare symposium next week to boost confidence in the private sector. Business leaders, including Alibaba co-founder Jack Ma, Tencent CEO Pony Ma, and Xiaomi’s Lei Jun, are expected to attend, along with executives from Huawei, Yushu Technology, and DeepSeek.
This event highlights the mounting challenges facing China’s private sector, including slowing domestic growth and escalating tensions with the U.S. over technology restrictions. Xi is expected to encourage business expansion both domestically and internationally amidst the ongoing Sino-U.S. tech war.
Jack Ma’s attendance is particularly significant, as he has largely remained out of the public eye since the 2020 suspension of Ant Group’s IPO, following his criticism of China’s regulatory system. The crackdown that followed reshaped China’s tech landscape, signaling increased government oversight.
Xi’s last major private sector symposium was in 2018, where he pledged tax cuts and financial support. Since then, his focus on “common prosperity” has emphasized wealth redistribution and corporate responsibility.
DeepSeek founder Liang Wenfeng’s participation further underscores China’s AI ambitions, as his startup has gained attention for developing AI models at lower costs than Western competitors. Xi continues to stress self-sufficiency in semiconductor production, though U.S. export controls remain a significant hurdle.
News of the symposium boosted Hong Kong-listed shares of Alibaba, Tencent, and Xiaomi, with gains of up to 7%. As China navigates economic headwinds, the meeting could be a crucial step in restoring investor and business confidence.


Flavio Bolsonaro Meets Trump, JD Vance, and Marco Rubio Amid Brazil Political Crisis
US Imposes Fresh Iran Oil Sanctions Despite Progress on Ceasefire Talks
Brazil Struggles to Stop Illegal Amazon Gold Mining as Gold Prices Surge
US Launches New Trade Investigation Into Vietnam Over Intellectual Property Concerns
JPMorgan Sees Biotech Sector at Turning Point, Upgrades Top Pharma Stocks
US Tightens Ebola Controls as Congo Outbreak Sparks Global Concern
DOJ Opens Criminal Investigation Into E. Jean Carroll Over Alleged Perjury
Snowflake Stock Soars 30% After Q1 Earnings Beat and Major AWS AI Partnership
CTOC Goes Live on Bitget Wallet Trading, Expanding Global Access to AI-Powered Healthcare Data Ecosystem
Dell Raises 2027 Revenue Forecast as AI Server Demand Drives Record Quarterly Results
Meta Subscription Push Could Add Billions in Recurring Revenue, Says Rosenblatt
HP Q2 2026 Earnings Beat Expectations Despite Memory Chip Pressure
SK Hynix Joins $1 Trillion Club as AI Chip Demand Fuels Stock Surge
Netanyahu Orders Expansion of Israeli Control in Gaza to 70%
UN Blacklists Israel and Russia Over Conflict-Related Sexual Violence Claims
Xiaomi Shares Drop After Weak Q1 Earnings Amid Rising Smartphone Costs
Blue Origin New Glenn Rocket Explodes During Launch Pad Test, Delaying Space Ambitions 



